Interference No. 103,906
Appendix
Count 1
A method for treating HIV infection in humans comprising
administering an effective amount of (-)-$-L-2-hydroxymethyl-5-
(5-fluorocytosin-1-yl)-1,3-oxanthiolane, or its physiologically
acceptable salt, optionally in a pharmaceutically acceptable
carrier;
or
a method for treating a viral infection in a mammal comprising
administering to a mammal in need thereof, an antiviral effective
amount of (-)-Cis-4-amino-5-fluoro-1-(2-hydroxymethyl-1,3-
oxanthiolan-5yl)-(1H)-pyrimidin-2-one or a pharmaceutically
acceptable salt, ester or salt of an ester thereof.
The claims of the parties which correspond to the count are:
Dionne: Claim 1.
Liotta et al.: Claims 26, 31-34, 39, 43 and 47.
Count 2
A method for treating HIV infection in humans comprising
administering an effective amount of (-)-$-L-2-hydroxymethyl-5-
(5-fluorocytosin-1,3-oxathiolane, or its physiologically
acceptable salt, optionally in a pharmaceutically acceptable
carrier;
or
a method for treating HIV infection in humans comprising
administering an effective amount of (+)-$-D-2-hydroxymethyl-
5(5-fluorocytosin-1-yl)-1,3-oxathiolane, or its physiologically
acceptable salt, optionally in a pharmaceutically acceptable
carrier;
or
A1
Page: Previous 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 Next
Last modified: November 3, 2007